NEOGENOMICS INC (NEO)

↓ Download CSV

CIK 0001077183 · Nasdaq · Services-Testing Laboratories

  • Sector Services
  • Incorporated NV
  • Fiscal year ends Dec 31

In fiscal 2025, NEOGENOMICS INC reported revenue of $727.33M, up 10.1% from the prior year. The company ran a net loss, with a net margin of -14.9% and a gross margin of 43.2%. It held $1.36B in total assets against $523.27M in total liabilities.

Key ratios (FY2025)

43.2%
Gross margin
-15.9%
Operating margin
-14.9%
Net margin
-12.9%
Return on equity
+10.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$727.33M$660.57M$591.64M$509.73M$484.33M$444.45M$408.83M$276.74M$240.25M$231.81M
Cost of Revenue$413.04M$370.47M$347.04M$321.83M$297.27M$258.56M$211.99M$149.48M$138.29M$133.70M
Gross Profit$314.29M$290.10M$244.60M$187.90M$187.06M$185.89M$196.84M$127.27M$101.96M$98.10M
Operating Income-$115.88M-$92.11M-$107.74M-$157.62M-$118.75M-$13.99M$13.01M$10.04M$2.90M$2.15M
Net Income-$108.03M-$78.73M-$87.97M-$144.25M-$8.35M$4.17M$8.01M$2.64M-$396.0K-$6.14M
Total Assets$1.36B$1.64B$1.68B$1.74B$1.87B$988.33M$709.51M$505.01M$344.45M$337.12M
Total Liabilities$523.27M$735.70M$739.69M$742.01M$761.50M$294.04M$202.10M$184.57M$139.88M$150.52M
Shareholders' Equity$836.56M$902.34M$941.54M$998.02M$1.11B$694.29M$507.41M$320.44M$171.96M$162.32M
Cash & Equivalents$159.62M$367.01M$342.49M$263.18M$316.83M$228.71M$173.02M$9.81M$12.82M$12.53M
Operating Cash Flow$5.23M$7.02M-$1.95M-$65.99M-$26.72M$1.46M$23.37M$44.79M$18.04M
Capital Expenditures$27.01M$41.06M$28.75M$30.89M$64.14M$29.10M$20.03M$14.31M$13.69M$7.54M
Shares Outstanding128.15M128.15M127.37M126.91M124.11M112.08M104.78M94.47M80.46M78.57M